3,686
Views
14
CrossRef citations to date
0
Altmetric
Clinical Study

Prevalence of hypothyroidism in Japanese chronic kidney disease patients

, , , , &
Pages 572-579 | Received 29 Dec 2019, Accepted 18 May 2020, Published online: 22 Jun 2020

References

  • Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner & Ingbar’s the thyroid. 9th ed. USA: Lippincott Williams & Wilkins; 2005. p. 697–699.
  • Chaker L, Sedaghat S, Hoorn EJ, et al. The association of thyroid function and the risk of kidney function decline: a population-based cohort study. Eur J Endocrinol. 2016;175(6):653–660.
  • Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012;16(2):204–213.
  • Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract. 2016;35(3):165–168.
  • Elgadi A, Verbovszki P, Marcus C, et al. Long-term effects of primary hypothyroidism on renal function in children. J Pediatr. 2008;152(6):860–864.
  • Rhee CM. The interaction between thyroid and kidney disease: an overview of the evidence. Curr Opin Endocrinol Diabetes Obes. 2016;23(5):407–415.
  • Squef R, Martinez M, Oppenheimer JH. Use of thyroxine-displacing drugs in identifying serum thyroxine-binding proteins separated by starch gel electrophoresis. Proc Soc Exp Biol Med. 1963;113:837–840.
  • Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–566.
  • Horio M, Imai E, Yasuda Y, et al. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61(2):197–203.
  • Nihon Jinzo G. Special issue: evidence-based practice guideline for the treatment of CKD. Nihon Jinzo Gakkai Shi. 2013;55(5):585–860.
  • Clinical Guidelines for Nephrotic Syndrome 2014 Advisory Committee. Evidence-based clinical practice guidelines for nephrotic syndrome; 2014. https://www.jsn.or.jp/en/guideline/pdf/NS_eng.pdf.
  • Montenegro J, Gonzalez O, Saracho R, et al. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996;27(2):195–198.
  • Khatiwada S, Rajendra KC, Gautam S, et al. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr Disord. 2015;15:65.
  • Rhee CM, Kalantar-Zadeh K, Streja E, et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant. 2015;30(2):282–287.
  • Iglesias P, Bajo MA, Selgas R, et al. Thyroid dysfunction and kidney disease: an update. Rev Endocr Metab Disord. 2017;18(1):131–144.
  • Shin DH, Lee MJ, Lee HS, et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid. 2013;23(6):654–661.
  • Kim EO, Lee IS, Choi YA, et al. Unsolved subclinical hypothyroidism is independently associated with progression of chronic kidney disease. Int J Med Sci. 2014;11(1):52–59.
  • Fan J, Yan P, Wang Y, et al. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monit. 2016;22:1171–1179.
  • Golden SH, Robinson KA, Saldanha I, et al. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853–1878.
  • Kasagi K, Takahashi N, Inoue G, et al. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid. 2009;19(9):937–944.
  • Kim WG, Chung JH. Response: thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106–14, Won Gu Kim et al.). Endocrinol Metab (Seoul). 2017;32(2):304–305.
  • Duntas LH. Thyroid function in aging: a discerning approach. Rejuvenat Res. 2018;21(1):22–28.
  • Jasim S, Gharib H. Thyroid and aging. Endocr Pract. 2018;24(4):369–374.
  • Benvenga S. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman LE, Utiger RD, editors. Werner & Ingbar’s the thyroid. 9th ed. USA: Lippincott Williams & Wilkins; 2005. p. 97–108.
  • Kapoor K, Saha A, Dubey NK, et al. Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome. Clin Exp Nephrol. 2014;18(1):113–117.
  • Purkait R, Mukherji A. Congenital nephrotic syndrome with hypothyroidism: an unusual association. J Coll Physicians Surg Pak. 2013;23(9):687–688.
  • Sharma S, Dabla PK, Kumar M. Evaluation of thyroid hormone status in children with steroid resistant nephrotic syndrome: a North India study. Endocr Metab Immune Disord Drug Targets. 2015;15(4):321–324.
  • Zha Y, Qian Q. Protein nutrition and malnutrition in CKD and ESRD. Nutrients. 2017;9(3):208–3390.
  • Amino N. Autoimmunity and hypothyroidism. Bailliere’s Clin Endocrinol Metab. 1988;2(3):591–617.
  • Fliers E, Bianco AC, Langouche L, et al. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816–825.
  • Nomura E, Nishimura K, Toyoda N. Thyroid hormones and critical illness. J Japan Thyroid Assoc. 2017;8(2):192–200.
  • Wierstinga WM, Van Den Berge G. Nonthyroidal illness. In: Braverman LE, Cooper DS, editors. The thyroid. 10th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2013. p. 15–17.
  • Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456–1465.
  • Lim SV. Thyroid hormone metabolism. In: Massry SG, Glassock RJ, editors. Massry & Glassock’s textbook of nephrology. 4th ed. USA: Lippincott Williams & Wilkins; 2001. p. 1361–1367.
  • Yan W, Wang L, Huang T, et al. Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study. J Nephrol. 2017;30(4):557–565.
  • Kaptein EM, LoPresti JS, Kaptein MJ. Is an isolated TSH elevation in chronic nonthyroidal illness “subclinical hypothyroidism”? J Clin Endocrinol Metab. 2014;99(11):4015–4026.
  • Nishikawa M. Japan Committee of Japan Thyroid Association for manual preparation for severe drug side effects. Drug induced thyroid toxicosis and hypothyroidism. J Japan Thyroid Assoc. 2012;3(1):19–23.
  • Haugen BR. Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab. 2009;23(6):793–800.